Deoxynivalenol: rationale for development and application of a urinary biomarker. - Wikidata - awgldk - TriplyDB

Deoxynivalenol: rationale for development and application of a urinary biomarker.

Deoxynivalenol: rationale for development and application of a urinary biomarker.

http://www.wikidata.org/entity/Q38441928

about

Evaluation of insulin-like growth factor acid-labile subunit as a potential biomarker of effect for deoxynivalenol-induced proinflammatory cytokine expression Proteomic analysis of the effects of the immunomodulatory mycotoxin deoxynivalenol.Suppression of insulin-like growth factor acid-labile subunit expression--a novel mechanism for deoxynivalenol-induced growth retardation Evaluation of an oral subchronic exposure of deoxynivalenol on the composition of human gut microbiota in a model of human microbiota-associated rats Deoxynivalenol-induced proinflammatory gene expression: mechanisms and pathological sequelae.Determination of Deoxynivalenol in the Urine of Pregnant Women in the UK.The Food Contaminant Deoxynivalenol Exacerbates the Genotoxicity of Gut Microbiota.The role of biomarkers in evaluating human health concerns from fungal contaminants in food.Characterisation of aflatoxin and deoxynivalenol exposure among pregnant Egyptian women.Deoxynivalenol Biomarkers in the Urine of UK Vegetarians.Advances in Mycotoxin Research: Public Health Perspectives.A comparison of deoxynivalenol intake and urinary deoxynivalenol in UK adults.Urine metabolite analysis as a function of deoxynivalenol exposure: an NMR-based metabolomics investigation.Simultaneous LC-MS/MS determination of aflatoxin M1, ochratoxin A, deoxynivalenol, de-epoxydeoxynivalenol, α and β-zearalenols and fumonisin B1 in urine as a multi-biomarker method to assess exposure to mycotoxins.Mycotoxin binder improves growth rate in piglets associated with reduction of toll-like receptor-4 and increase of tight junction protein gene expression in gut mucosa.Assessment of Urinary Deoxynivalenol Biomarkers in UK Children and Adolescents.Diagnosis of intoxications of piglets fed with Fusarium toxin-contaminated maize by the analysis of mycotoxin residues in serum, liquor and urine with LC-MS/MS.Annual variation of dietary deoxynivalenol exposure during years of different Fusarium prevalence: a pilot biomonitoring study.Humans significantly metabolize and excrete the mycotoxin deoxynivalenol and its modified form deoxynivalenol-3-glucoside within 24 hours.Comparison of single and multi-analyte methods based on LC-MS/MS for mycotoxin biomarker determination in human urine

P2860

Q33697732-924DC777-FFBA-4DA7-A302-66E4ECEC8E4F Q33861765-BDA74ADD-FB24-422B-9997-617C664CE595 Q33988934-9E67EACC-C2BE-4689-8C5F-DF9A6FB45978 Q35049126-2CCCA9F8-AE42-4EEF-A5BF-553AE9E356FA Q35155832-29B78E81-54E4-4FA0-AECE-C743449F292A Q37450350-67BFCB94-AC82-4405-BB8F-DC8F7482F74B Q37700056-9C1905AD-EDAD-44A2-A610-CD7D4145521E Q38014991-7DE4F041-F75B-49E5-96EC-8F66BF1EEACE Q39355569-4834A916-D31A-4FB7-A0AC-E3C78C010A36 Q40149644-AAB00CE2-3392-4DFE-B93A-DE26F7F05D7A Q40324481-AF0B5183-AB2A-410D-A425-1D6919439921 Q43007757-D02416E9-A77C-436C-BCEC-68D73A036716 Q43219491-AEC738CF-4024-4146-870A-6CD1C1201107 Q45206156-BC278DDF-531A-400C-8627-551E27DC089F Q46265212-7ABCDC91-F106-48B6-AC42-9DF78919F772 Q47550024-0E05756B-B722-445A-981D-14A6B28E0F97 Q51018559-A5E54990-CE73-474E-BDF1-0C561F7AE2A1 Q51251897-236AB0C8-D472-4E65-B1BA-AB21226FF5C1 Q52626721-FD3687A0-2826-478C-BDDF-432321EA8BD7 Q56838884-844B08A9-CAC6-48CF-AEE9-767F7C0A44AE

P2860

Deoxynivalenol: rationale for development and application of a urinary biomarker.

http://www.wikidata.org/entity/Q38441928

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Deoxynivalenol: rationale for development and application of a urinary biomarker.

@en

Deoxynivalenol: rationale for development and application of a urinary biomarker.

@en-gb

type

label

Deoxynivalenol: rationale for development and application of a urinary biomarker.

@en

Deoxynivalenol: rationale for development and application of a urinary biomarker.

@en-gb

prefLabel

Deoxynivalenol: rationale for development and application of a urinary biomarker.

@en

Deoxynivalenol: rationale for development and application of a urinary biomarker.

@en-gb

P1433

Q38441928-5E6456EB-F58E-4C9A-A2F6-0289D692C1E0

P1476

Q38441928-7F36472A-1D21-4EE9-8607-B135E32880E0

P2093

Q38441928-008F700D-2793-49A2-99B9-1DADDC5284C0

Q38441928-3F587AF6-FDDD-4FD7-9167-03B2D100D0BD

Q38441928-BF09D2F1-9F91-496B-9461-74BBDADD2B71

Q38441928-EFC4277B-9D7E-4986-858F-EE3DA4F8DBA9

P2860

Q38441928-0660DD82-3C40-4A55-BCB0-DCF41FC3B52B

Q38441928-0AB79396-7B36-4ECA-BF0A-0FBA972225F7

Q38441928-135F98B0-2217-4AA3-B679-DCD2A0C43B68

Q38441928-17A3187C-1257-4196-B5B6-631D7385FBCA

Q38441928-17A5A5E4-E2E4-40FC-B522-F855D047D665

Q38441928-18603D0A-D70F-4346-AE92-2244627B6AE3

Q38441928-1D2F3507-88C7-4C91-95B0-4ECB6BBC8849

Q38441928-38438902-7A4A-4132-8D11-2BBE195B983B

Q38441928-3DD915F1-EA49-478A-AF87-D97C6E4DAE42

Q38441928-49A5E621-10B0-42D5-843E-D643008E4175

P304

Q38441928-03611F72-4A87-46CC-8C45-11F525130E88

P31

Q38441928-0C19AB47-E6BF-447B-9624-A498882F42E7

P356

Q38441928-F529C790-D8A9-425B-86A9-F555ACABF3BE

P433

Q38441928-BDFE13D7-FCE0-4E58-89E9-FEEC174F9F41

P478

Q38441928-FF26D215-610D-472A-A838-5C3C6239E03D

P50

Q38441928-31AC2919-CB2B-4FEB-B423-0F81397564D0

Q38441928-EB4C8297-14A8-42F0-BED1-D5421575D452

P577

Q38441928-DF8D24EB-0075-4E9C-B023-D5A689CEEBBD

P5875

Q38441928-32F74879-1E51-41BE-B73E-8C50C3599603

P698

Q38441928-4DF76235-1B73-4906-A159-6FE2353722DF

P921

Q38441928-6CCD94DC-8B8C-4654-8AC7-0A2A6F5493C2

Q38441928-C1703C54-9278-4EC7-BC53-30E198F19814

P356

02652030801895040

P1433

Food Additives and Contaminants Part A

P1476

Deoxynivalenol: rationale for development and application of a urinary biomarker.

@en

P2093

Christopher P Wild

http://www.w3.org/2001/XMLSchema#string

Joseph A Rothwell

http://www.w3.org/2001/XMLSchema#string

Kay L M White

http://www.w3.org/2001/XMLSchema#string

Paul C Turner

http://www.w3.org/2001/XMLSchema#string

P2860

The toxicology of aflatoxins as a basis for public health decisions

Combined toxic effects of mycotoxins

Toxicity data relevant for hazard characterization.

Fumonisin contamination of food: progress in development of biomarkers to better assess human health risks.

Immunomodulation by fungal toxins.

A critical evaluation of the application of biomarkers in epidemiological studies on diet and health.

Hepatocellular carcinoma: from gene to public health.

Update of survey, regulation and toxic effects of mycotoxins in Europe.

Deoxynivalenol-induced IgA production and IgA nephropathy-aberrant mucosal immune response with systemic repercussions.

Cellular and molecular mechanisms for immune modulation by deoxynivalenol and other trichothecenes: unraveling a paradox.

P304

864-871

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/02652030801895040

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P50

Victoria J. Burley

Janet Elizabeth Cade

P577

2008-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5287591

http://www.w3.org/2001/XMLSchema#string

P698

18569005

http://www.w3.org/2001/XMLSchema#string

P921